Document Detail

Oestrogens reconsidered.
MedLine Citation:
PMID:  7754279     Owner:  NLM     Status:  MEDLINE    
Oestrogen therapy or orchidectomy reigned supreme for the treatment of metastatic prostatic cancer for almost 40 years. In the last 15 years many alternative agents have been tested alone and more recently in combination. This contribution evaluates the results of some of these newer therapies considering relief of symptoms, toxicity, quality of life, survival, and benefit to the community. The results are compared with those of oestrogen therapy and with the way in which such treatment might be amended in light of more modern knowledge.
P H Smith
Related Documents :
17057389 - Prospective controlled cohort studies on long-term therapy of breast cancer patients wi...
22500259 - History of minimally invasive surgery for gastric cancer in korea.
1749589 - Reticulum cell sarcoma: two complete 'spontaneous' regressions, in response to high-dos...
3001379 - Immunoaugmentative therapy. a primer on the perils of unproved treatments.
22221059 - Metabolomics: a revolution for novel cancer marker identification.
22792519 - Amplification of the uqcrfs1 gene in gastric cancers.
10799919 - Human dendritic cells transfected with rna encoding prostate-specific antigen stimulate...
16222169 - Analysis of mortality data from cancer screening studies: looking in the right window.
24041709 - Hpma copolymer-based combination therapy toxic to both prostate cancer stem/progenitor ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in surgical oncology     Volume:  11     ISSN:  8756-0437     ISO Abbreviation:  Semin Surg Oncol     Publication Date:    1995 Jan-Feb
Date Detail:
Created Date:  1995-06-16     Completed Date:  1995-06-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8503713     Medline TA:  Semin Surg Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  72-6     Citation Subset:  IM    
Department of Urology, St. James's University Hospital, Leeds, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Combined Modality Therapy
Estrogens / therapeutic use*
Neoplasm Metastasis
Neoplasm Staging
Prostatic Neoplasms / drug therapy*,  mortality,  pathology,  surgery
Randomized Controlled Trials as Topic
Risk Factors
Survival Rate
Treatment Outcome
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  European trials and the management of prostate cancer.
Next Document:  Anatomy of the prostate and distribution of early prostate cancer.